Library › Molecules › Approved drugs · Various (diagnostics, antidotes)
Approved drugs · Various (diagnostics, antidotes): 58 3D models
Water, gases, sugars, nucleotides, amino acids, ions (real sizes 0.1–1 nm). Each one is a ready-made 3D model you can turn, recolour and place in a figure — open BioDioRama and type its name in the Library search.
- Flumazenil — Approved medicine — all other therapeutic products, first approved 1991. C15H14FN3O3, 303.29 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Aminohippuric acid — Approved medicine — diagnostic agents, first approved 1982. C9H10N2O3, 194.19 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Macimorelin — Approved medicine — diagnostic agents, first approved 2017. C26H30N6O3, 474.57 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Tolbutamide — Approved medicine — diagnostic agents, first approved 1961. C12H18N2O3S, 270.35 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Iopanoic acid — Approved medicine — contrast media, first approved 1951. C11H12I3NO2, 570.93 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Metyrapone — Approved medicine — diagnostic agents, first approved 1961. C14H14N2O, 226.28 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Iophendylate — Approved medicine — contrast media, first approved 1982. C19H29IO2, 416.34 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Mesna — Approved medicine — all other therapeutic products, first approved 1988. C2H5NaO3S2, 164.18 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Methacholine — Approved medicine — diagnostic agents, first approved 1986. C8H18NO2+, 160.24 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Deferiprone — Approved medicine — all other therapeutic products, first approved 1999. C7H9NO2, 139.15 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Amifostine — Approved medicine — all other therapeutic products, first approved 1995. C5H15N2O3PS, 214.23 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Edrophonium — Approved medicine — diagnostic agents, first approved 1951. C10H16NO+, 166.24 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Fomepizole — Approved medicine — all other therapeutic products, first approved 1997. C4H6N2, 82.11 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Pentagastrin — Approved medicine — diagnostic agents, first approved 1974. C37H49N7O9S, 767.91 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Pralidoxime — Approved medicine — all other therapeutic products, first approved 1964. C7H9N2O+, 137.16 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Diazoxide — Approved medicine — all other therapeutic products, first approved 1973. C8H7ClN2O2S, 230.68 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Fluciclovine f18 — Approved medicine — diagnostic radiopharmaceuticals, first approved 2016. C5H8FNO2, 132.12 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Nalfurafine — Approved medicine — all other therapeutic products, first approved 2009. C28H32N2O5, 476.57 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Metrizamide — Approved medicine — contrast media, first approved 1978. C18H22I3N3O8, 789.1 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Dimercaprol — Approved medicine — all other therapeutic products, first approved 1946. C3H8OS2, 124.23 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Iopromide — Approved medicine — contrast media, first approved 1995. C18H24I3N3O8, 791.11 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Metrizoic acid — Approved medicine — contrast media, first approved 1982. C12H11I3N2O4, 627.94 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Deferasirox — Approved medicine — all other therapeutic products, first approved 2005. C21H15N3O4, 373.37 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Dexrazoxane — Approved medicine — all other therapeutic products, first approved 1995. C11H16N4O4, 268.27 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Florbetaben f18 — Approved medicine — diagnostic radiopharmaceuticals, first approved 2014. C21H26FNO3, 358.44 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Iodipamide — Approved medicine — contrast media, first approved 1982. C20H14I6N2O6, 1139.76 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Bentiromide — Approved medicine — diagnostic agents, first approved 1983. C23H20N2O5, 404.42 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Ioversol — Approved medicine — contrast media, first approved 1988. C18H24I3N3O9, 807.11 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Xenon xe 127 — Approved medicine — diagnostic radiopharmaceuticals, first approved 1982. Xe, 126.91 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Iocetamic acid — Approved medicine — contrast media, first approved 1982. C12H13I3N2O3, 613.96 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Propyliodone — Approved medicine — contrast media, first approved 1982. C10H11I2NO3, 447.01 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Perflubron — Approved medicine — contrast media, first approved 1993. C8BrF17, 498.96 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Ioxilan — Approved medicine — contrast media, first approved 1995. C18H24I3N3O8, 791.11 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Krypton kr 81m — Approved medicine — diagnostic radiopharmaceuticals, first approved 1982. Kr, 80.92 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Diatrizoic acid — Approved medicine — contrast media, first approved 1954. C11H9I3N2O4, 613.91 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Iodamide — Approved medicine — contrast media, first approved 1982. C12H11I3N2O4, 627.94 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Tyropanoic acid — Approved medicine — contrast media, first approved 1969. C15H18I3NO3, 641.02 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Ioxaglic acid — Approved medicine — contrast media, first approved 1985. C24H21I6N5O8, 1268.88 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Iothalamic acid — Approved medicine — contrast media, first approved 1962. C11H9I3N2O4, 613.91 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Indocyanine green acid form — Approved medicine — diagnostic agents, first approved 1959. C43H48N2O6S2, 753 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Betazole — Approved medicine — diagnostic agents, first approved 1982. C5H9N3, 111.15 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Acetrizoic acid — Approved medicine — contrast media, first approved 1982. C9H6I3NO3, 556.86 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Thiosulfuric acid — Approved medicine — all other therapeutic products, first approved 1992. H2O3S2, 114.15 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Iodoxamic acid — Approved medicine — contrast media, first approved 1982. C26H26I6N2O10, 1287.92 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Florbetapir f 18 — Approved medicine — diagnostic radiopharmaceuticals, first approved 2012. C20H25FN2O3, 359.43 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Helium — Approved medicine — all other therapeutic products, first approved 2015. He, 4 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Perflenapent — Approved medicine — contrast media, first approved 1998. C5F12, 288.03 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Fludeoxyglucose f 18 — Approved medicine — diagnostic radiopharmaceuticals, first approved 1994. C6H11FO5, 181.15 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Cobicistat — Approved medicine — all other therapeutic products, first approved 2012. C40H53N7O5S2, 776.04 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Iomeprol — Approved medicine — contrast media, first approved 2024. C17H22I3N3O8, 777.09 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Ioxitalamic acid — Approved medicine — contrast media. C12H11I3N2O5, 643.94 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Radium ra 223 dichloride — Approved medicine — therapeutic radiopharmaceuticals, first approved 2013. Cl2Ra, 293.92 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Methiodal — Approved medicine — contrast media. CH3IO3S, 222 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Fluorodopa f 18 — Approved medicine — diagnostic radiopharmaceuticals, first approved 2019. C9H10FNO4, 214.18 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Flortaucipir f 18 — Approved medicine — diagnostic radiopharmaceuticals, first approved 2020. C16H10FN3, 262.28 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Trilaciclib — Approved medicine — all other therapeutic products, first approved 2021. C24H30N8O, 446.56 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Piflufolastat f18 — Approved medicine — diagnostic radiopharmaceuticals, first approved 2021. C18H23FN4O8, 441.4 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Gallium ga 68 gozetotide — Approved medicine — diagnostic radiopharmaceuticals, first approved 2020. C44H61GaN6O18, 1029.92 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.